Zhi et al. have proposed that loss of CXCL12 and maintenance of CXCR4 expression imparts metastatic cancer cells a phenotype similar to highly migratory circulating leukocytes and lymphocytes22, 41. This evidence concerns the gene CXCR4 and cancer.